There’s No Escaping Assembly Biosciences, Inc.’s (NASDAQ:ASMB) Muted Revenues Despite A 28% Share Price Rise
Explore Assembly Biosciences’s Fair Values from the Community and select yours
Despite an already strong run, Assembly Biosciences, Inc. (NASDAQ:ASMB) shares have been powering on, with a gain of 28% in the last thirty days. Looking back a bit further, it’s encouraging to see the stock is up 83% in the last year.
Although its price has surged higher, Assembly Biosciences may still be sending bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 5.5x, since almost half of all companies in the Biotechs industry in the United States have P/S ratios greater than 7.9x and even P/S higher than 61x are not unusual. However, the P/S might be low for a reason and it…